IPP Bureau
Krsnaa Diagnostics bags large tender in Maharashtra
By IPP Bureau - July 26, 2022
The tenure of contract will be upto 10 years from date of signing the contract/installation.
Vikas Lifecare consolidated Q1FY23 PAT at Rs. 2.59 Cr
By IPP Bureau - July 26, 2022
The company has reported total income of Rs. 94.30 crores during the period ended June 30, 2022.
GlaxoSmithKline Pharmaceuticals Q1FY23 consolidated PAT at Rs. 119.28 Cr
By IPP Bureau - July 26, 2022
GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022
Lupin receives approval from U.S. FDA for Azilsartan Medoxomil Tablets
By IPP Bureau - July 26, 2022
The product will be manufactured at Lupin's facility in Nagpur, India.
Urinary incontinence 2nd biggest reason for limited mobility in elderly: Survey
By IPP Bureau - July 26, 2022
72.5% elderly feel their generation used to spend more time with their elders, 52.4% feel lonely, shows PAN Health’s Liberty in Life of Older People 2022 survey
Cadila Pharma bags ‘Rising Digital Star’ award at DigipharmaX
By IPP Bureau - July 26, 2022
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
Healthcare Triangle launches in Singapore; Leveraging AI and cloud in Asia Pacific Markets
By IPP Bureau - July 26, 2022
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
Suven Life Sciences posts Q1FY23 consolidated loss at Rs. 16.32 Cr
By IPP Bureau - July 26, 2022
Suven Life Sciences has reported total income of Rs. 3.97 crores during the period ended June 30, 2022
Sanofi India Q2 CY2022 PAT drops 49.5% to Rs. 120.4 Cr
By IPP Bureau - July 26, 2022
Sanofi India has reported total income of Rs. 715 crores during the period ended June 30, 2022.
Zydus receives final approval from the USFDA for Bisoprolol Fumarate Tablets
By IPP Bureau - July 26, 2022
Bisoprolol Fumarate Tablets are used to treat high blood pressure.
Sun Pharma and Cosmo announce territory expansion of license and supply agreements for WINLEVI
By IPP Bureau - July 26, 2022
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
Dabur launches 'Dabur Himalayan Shilajit'
By IPP Bureau - July 26, 2022
Funds for R&D in drug discovery and manufacturing :PIB
By IPP Bureau - July 26, 2022
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
Bug Bite Thing partnership with certified pediatrician Dr. Mona Amin
By IPP Bureau - July 25, 2022
Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.
WuXi STA opens a new large scale continuous manufacturing plant at Changzhou site
By IPP Bureau - July 24, 2022
WuXi STA opens a new large scale continuous manufacturing plant
